Trials / Completed
CompletedNCT05124275
Safety and Efficacy of Pilocarpine Ophthalmic Topical Cream for the Treatment of Presbyopia
Multicenter, Randomized, Double-Masked, Placebo-Controlled, Parallel Group Phase 2 Trial Evaluating the Safety and Efficacy of Pilocarpine Ophthalmic Topical Cream BID for the Treatment of Presbyopia
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 123 (actual)
- Sponsor
- Glaukos Corporation · Industry
- Sex
- All
- Age
- 40 Years – 55 Years
- Healthy volunteers
- Not accepted
Summary
This is a Multicenter, Randomized, Double-Masked Placebo-Controlled, Parallel Group Phase 2 Trial Evaluating the Safety and Efficacy of Pilocarpine Ophthalmic Topical Cream for the Treatment of Presbyopia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Pilocarpine Ophthalmic Topical Cream, Dose 1 | Pilocarpine Ophthalmic Topical Cream, Dose 1 |
| DRUG | Pilocarpine Ophthalmic Topical Cream, Dose 2 | Pilocarpine Ophthalmic Topical Cream, Dose 2 |
| DRUG | Pilocarpine Ophthalmic Topical Cream, Dose 3 | Pilocarpine Ophthalmic Topical Cream, Dose 3 |
| DRUG | Placebo Ophthalmic Topical Cream | Placebo Ophthalmic Topical Cream |
Timeline
- Start date
- 2022-01-03
- Primary completion
- 2022-09-06
- Completion
- 2022-09-06
- First posted
- 2021-11-17
- Last updated
- 2023-09-01
Locations
10 sites across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT05124275. Inclusion in this directory is not an endorsement.